Fenretinide (4-HPR)

Name: Fenretinide (4-HPR); MyBioSource
Brand: MyBioSource
SKU: MBS3605494
Price: 215 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3605494

Fenretinide (4-HPR) is a synthetic retinoid deriverative. 4-HBR is shown to exhibit binding to the retinoic acid receptors (RAR) at concentrations necessary to induce cell death. More details

$215 / 5 mg +1 FREE 8GB USB

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

Fenretinide, Biochemical

Full Product Name

Fenretinide

Product Synonym Names

4-HPR; 4-Hydroxy (phenyl)retinamide; MK-4016; Retinoic Acid p-hydroxyphenylamide; Ro 22-4667

Purity/Purification

>98% (HPLC)

Preparation and Storage

Store at -20 degree C
Stability: >=2 years
Shipping: Ice Pack

Molecular Weight

391.55

Suitability

DMSO: >=100mM)

Target

Retinoid Receptor

Receptor

RAR/RAX

Chemical Name

(2E, 4E, 6E, 8E)-N-(4-hydroxyphenyl)-3, 7-dimethyl-9-(2, 6, 6-trimethylcyclohex-1-en-1-yl)nona-2, 4, 6, 8-tetraenamide

SMILES

O=C(NC1=CC=C(O)C=C1)/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C

Molecular Formula

C26H33NO2

CAS Number

65646-68-6

Product Categories/Family for Fenretinide biochemical

Metabolic Enzyme/Protease; Cancer

Product References and Citations for Fenretinide biochemical

1.Manzano VM, et al. J Pharmacol Exp Ther, 1999, 289 (1), 123-132.

Other Notes

Small volumes of Fenretinide biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Fenretinide purchase

MBS3605494 is a biochemical targeting Fenretinide.